Albert David Ltd.

•

albertdavidindia.comBSE: 524075NSE: ALBERTDAVD

Market Cap₹ 483 Cr.

Current Price

High / Low₹ 932 / 580

Stock P/E21.4

Book Value₹ 742

Price to Book0.86

Dividend Yield0.59 %

ROCE0.8 %

ROE-0.4 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company is almost debt free
Latest quarter profit grew 303.0% YoY, showing strong momentum
Company has a consistent dividend-paying track record

CONS

Company is loss-making at the operating / net level
A large part of profit comes from other income (1419.9% of PBT)
Operating cash flow has been negative in recent years
Receivables are growing faster than sales - a possible quality concern
Company has a low return on equity of 8.6% over last 3 years
Interest coverage is weak at 1.2x - earnings barely cover interest

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1842.00	36.54	441957.50	0.87	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9326.00	84.64	247576.00	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4975.00	86.76	189233.01	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1119.50	24.74	111670.55	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1365.00	32.72	110272.68	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1970.35	97.37	106460.42	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	DRREDDY	1161.00	30.07	96906.38	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
8.	AUROPHARMA	1675.45	25.97	96401.69	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
9.	LUPIN	2096.00	17.34	95842.92	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
10.	MANKIND	2277.00	46.04	94050.37	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2416.90	37.94	68210.88	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	ALBERTDAVD	846.15	21.40	482.91	0.59	32.00	303.00	101.34	43.60	0.83	10.49

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	92	93	88	89	89	98	83	75	71	87	90	86	101
	79	77	80	79	88	92	82	80	81	85	79	83	94
Operating Profit	13	16	8	10	1	6	1	-5	-11	3	11	3	8
OPM %	14.13%	17.14%	9.46%	10.75%	0.98%	6.33%	0.81%	-6.34%	-15.09%	2.91%	12.04%	3.20%	7.73%
	18	12	17	10	23	21	-9	-5	22	-2	12	-25	28
Interest	0	0	0	0	0	0	0	0	1	1	1	0	1
Depreciation	2	1	2	2	2	2	2	2	2	2	2	3	2
Profit before Tax	29	27	23	18	22	25	-10	-12	8	-3	20	-25	36
Tax %	19.53%	23.54%	20.14%	28.71%	14.60%	28.09%	7.58%	12.53%	5.92%	-27.91%	23.12%	15.06%	10.61%
Net Profit	23	20	19	13	19	18	-9	-10	8	-3	15	-21	32
	41.16	35.57	32.80	22.63	33.02	31.67	-16.45	-18.10	13.91	-5.79	26.81	-37.56	56.07

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	295	290	317	321	247	314	342	362	346	334	364
	277	275	288	290	228	273	297	315	343	328	340
Operating Profit	18	16	29	31	19	41	44	47	3	6	24
OPM %	6.13%	5.44%	9.22%	9.51%	7.79%	13.06%	13.02%	12.96%	0.91%	1.72%	6.57%
	16	10	21	7	17	16	15	58	30	7	13
Interest	1	1	1	1	1	1	1	0	1	3	3
Depreciation	8	8	7	8	8	9	9	7	7	10	10
Profit before Tax	26	16	43	29	27	47	51	97	25	1	28
Tax %	37.54%	38.22%	37.84%	33.80%	19.31%	25.45%	28.70%	22.48%	31.82%	384.76%	19.06%
Net Profit	16	10	27	19	22	35	36	75	17	-1	23
EPS	0.00	0.00	0.00	0.00	38.80	61.78	63.39	132.15	30.14	-2.62	—
Dividend Payout %	19.67%	31.90%	12.85%	20.84%	15.46%	14.57%	14.20%	8.70%	16.59%	-190.91%	—

COMPOUNDED SALES GROWTH

10 Years:: 0%
5 Years:: 6%
3 Years:: -1%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: 11%
5 Years:: 7%
3 Years:: 4%
1 Year:: 5%

RETURN ON EQUITY

10 Years:: 10%
5 Years:: 10%
3 Years:: 9%
Last Year:: 0%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	6	6	6	6	6	6	6	6	6	6
	177	180	205	217	239	274	306	377	387	386
	35	32	5	6	5	7	7	4	13	29
Trade Payables	27	32	30	38	25	30	32	34	38	33
	106	111	130	131	131	158	162	183	182	184
Total Liabilities	351	361	376	398	405	475	512	604	625	637
	87	83	77	91	84	88	80	83	99	100
Capital Work in Progress	7	3	3	2	1	1	3	7	2	21
	59	68	113	122	138	183	193	273	260	243
	51	43	44	43	36	39	51	44	64	58
	0	0	0	0	0	0	0	29	27	34
Cash & Bank	15	26	7	7	35	19	25	31	2	33
	133	138	132	134	112	146	161	137	171	148
Total Assets	351	361	376	398	405	475	512	604	625	637

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	31	37	38	45	39	53	26	46	-28	-8
Cash from Investing	-37	-11	-19	-20	-39	-40	-5	-33	23	-4
Cash from Financing	7	-5	-17	-10	-2	-2	-6	-8	0	12
	-10	14	-4	-0	-4	-1	-1	4	-5	-0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	62.13	62.13	62.13	62.24	62.24	62.24	62.24	62.24	62.24
	0.80	0.88	0.86	1.00	0.84	0.60	0.60	0.58	0.57
	1.67	1.63	1.63	1.64	1.65	1.65	1.65	1.65	1.63
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	35.40	35.35	35.37	35.11	35.26	35.50	35.50	35.52	35.56

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-11

Copy of Newspaper Publication

2026-09-11 - Albert David Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-29

Shareholders meeting

2026-08-29 - Albert David Limited has informed the Exchange with copy of minutes of Annual General Meeting held on August 06, 2026

2026-08-07

Shareholders meeting

2026-08-07 - Albert David Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 06, 2026. Further, the company has informed the Exchange regarding voting results.

2026-08-07

Copy of Newspaper Publication

2026-08-07 - Albert David Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-07

Shareholders meeting

2026-08-07 - Albert David Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 06, 2026

2026-08-06

Resignation of Director/KMP/SMP

2026-08-06 - Albert David Limited has informed the Exchange about Resignation of Director/KMP/SMP

2026-08-06

Change in Management

2026-08-06 - Albert David Limited has informed the Exchange about change in Management

2026-08-06

Resignation of Director/KMP/SMP

2026-08-06 - Albert David Limited has informed the Exchange about Resignation of Director/KMP/SMP

2026-08-06

Outcome of Board Meeting

2026-08-06 - Albert David Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

News

Recent coverage and analyst commentary for ALBERTDAVD

Loading news…

🤖

AI Stock Analyst

Albert David Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account